Carl Nechtman, MD
Neurological Surgery · Birmingham, ALNPI 1366839235
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,591 of the $3,604 with a category attached, or 71.9%. 16 manufacturers reported payments, led by Stryker at 33.7% of the total.
Across 63 payments — averaging $57.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Medtronic$1K
- Providence Medical Technology, Inc.$384
- Globus Medical$233
- Spineology Inc.$157
- Johnson & Johnson$115
- plus $474 from 10 others
What the payments were for
- Travel & lodging$1,01428%
- Food & beverage$2,59172%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 9 | $1,216 |
| Medtronic | 18 | $1,025 |
| Providence Medical Technology, Inc. | 5 | $384 |
| Globus Medical | 7 | $233 |
| Spineology Inc. | 3 | $157 |
| Johnson & Johnson(2 entities) | 3 | $115 |
| Spine Wave, Inc. | 1 | $98 |
| Cerapedics Inc. | 1 | $91 |
| DJO, LLC | 3 | $71 |
| Integra Lifesciences Corporation | 2 | $60 |
| Orthofix Medical, Inc. | 6 | $48 |
| Nevro Corp. | 1 | $30 |
| Bioventus LLC | 1 | $21 |
| Vertex | 1 | $20 |
| Arteriocyte Medical Systems, Inc. | 1 | $19 |
| Kls-martin L.p. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,604 in reported general payments places this provider in the 55th percentile of 97 neurological surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methocarbamol | 177 | $1,615 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 92 | $1,101 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 83 | $855 |
| Celecoxib | 47 | $832 |
| Gabapentin | 49 | $430 |
| Pregabalin | 15 | $356 |
| Cyclobenzaprine Hcl | 26 | $197 |
| Methylprednisolone | 19 | $176 |
| Levetiracetam | 15 | $143 |
| Tizanidine Hcl | 14 | $129 |
| Tramadol Hcl | 21 | $98 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Birmingham
- Mark HadleyBirmingham$104K
- Andrew ErwoodBirmingham$85K
- Marshall HollandBirmingham$81K
- Jakub GodzikBirmingham$56K
- Adnan ShahidBirmingham$50K
- Jasmine ThumBirmingham$39K
- Jessica BentleyBirmingham$27K
- John FiveashBirmingham$12K
- Joshua MenendezBirmingham$11K
- Zenko HrynkiwBirmingham$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.